Log in to search using one of your social media accounts:

 

Virological Response of Daclatasvir Plus Sofosbuvir for HCV Virological Response of Daclatasvir Plus Sofosbuvir for HCV
The results of this study support a regimen of daclatasvir plus sofosbuvir, with or without ribavirin, in patients with chronic HCV infection, including those with severe liver disease.Gut (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 16, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

DAA Combination Confirmed Highly Effective Against HCV in Real-word Setting
Sustained virologic response was seen in 99% of subjects, reflecting rates seen in pre-registration studies. Adverse events were mild. (Source: ConsultantLive)
Source: ConsultantLive - November 14, 2016 Category: Internal Medicine Authors: Mark L. Fuerst Tags: Hepatitis C Source Type: news

DAA Combination Confirmed Highly Effective Against HCV in Real-world Setting
Sustained virologic response was seen in 99% of subjects, reflecting rates seen in pre-registration studies. Adverse events were mild. (Source: ConsultantLive)
Source: ConsultantLive - November 14, 2016 Category: Internal Medicine Authors: Mark L. Fuerst Tags: Hepatitis C Source Type: news

Merck Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates of Sustained Virologic Response in People with Genotypes 1, 2 or 3 Infection
Dateline City: KENILWORTH, N.J. Phase 2 Data Presentations at The Liver Meeting® Detail SVR12 Rates from Two Studies as Well as SVR8 Rates in Patients for Whom Direct-Acting Antiviral Treatment Previously FailedKENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the presentation of results from three Phase 2 clinical trials evaluating MK-3682B (MK-3682/grazoprevir/ruzasvir1), the company ’s investigational all-oral, triple-combination regimen for the treatment of chronic hepatitis C (HCV) infection (informally referred ...
Source: Merck.com - Corporate News - November 13, 2016 Category: Pharmaceuticals Tags: Hepatitis C Newsroom Corporate News Latest News #Merck #MRK $MRK MSD Source Type: news

A Promising Study Reveals New Hope For An HIV Cure
A new experimental HIV vaccine, when combined with a compound that stimulates a person’s immune system, demonstrated potential for a path to curing HIV. The small study, involving rhesus monkeys who had the monkey equivalent of HIV, revealed that this novel combination was effective at suppressing the virus to undetectable levels in a few of the subjects, without the need for antiretroviral treatments.  If the combination of the HIV vaccine and immune system compound is shown to be effective in people, it could mean one step toward a cure for HIV, said lead investigator Dan Barouch, director for the Center for V...
Source: Healthy Living - The Huffington Post - November 11, 2016 Category: Consumer Health News Source Type: news

A Promising Study Reveals New Hope For An HIV Cure
A new experimental HIV vaccine, when combined with a compound that stimulates a person’s immune system, demonstrated potential for a path to curing HIV. The small study, involving rhesus monkeys who had the monkey equivalent of HIV, revealed that this novel combination was effective at suppressing the virus to undetectable levels in a few of the subjects, without the need for antiretroviral treatments.  If the combination of the HIV vaccine and immune system compound is shown to be effective in people, it could mean one step toward a cure for HIV, said lead investigator Dan Barouch, director for the Center for V...
Source: Science - The Huffington Post - November 11, 2016 Category: Science Source Type: news

Investigational HIV therapeutic vaccine found to control SIV in preclinical studies
Researchers have found that an investigational treatment combining therapeutic vaccine and an immune stimulator was successful for improving virologic control and delay viral rebound after the discontinuation of anti-retroviral therapy (ART). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - November 11, 2016 Category: Pharmaceuticals Source Type: news

Predators can drive increase in virus populations, new study shows
(University of Nebraska-Lincoln) In what scientists say could be a potential 'game-changer' in the study of virology, a new study shows that a predator's consumption of prey can catalyze the natural rise and fall of chlorovirus populations. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 10, 2016 Category: Biology Source Type: news

Investigational HIV therapeutic vaccine approach helps control SIV in preclinical studies
(The U.S. Military HIV Research Program (MHRP)) An investigational treatment combination of a therapeutic vaccine and an immune-stimulator improves virologic control and delays viral rebound following the discontinuation of antiretroviral therapy in non-human primates infected with SIV. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 9, 2016 Category: Global & Universal Source Type: news

NCI grant funds SMU research into cancer-causing viruses that hide from the immune system
(Southern Methodist University) The National Cancer Institute is funding research at Southern Methodist University, Dallas, into cancer-causing viruses that hide from the immune system. Genes common to both the human T-cell leukemia virus and high-risk human papillomaviruses activate survival mechanisms in cancer cells. SMU virologist and cancer researcher Robert Harrod leads his lab's effort to find ways to inhibit those genes to halt the development of cancer. The hope is to ultimately develop a chemotherapy drug. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2016 Category: Global & Universal Source Type: news

A Virus Mutation Is What Made The 2014 Ebola Outbreak So Deadly
The Ebola outbreak that devastated West Africa in 2014 was a product of multiple factors, including a population that relies increasingly on global travel, poverty and inadequate public health infrastructure on the ground and local burial practices that conflicted with medical advice. Now, we know about another factor that helped the outbreak spread: the virus mutated. Mutation is standard among viruses, and according to two cell model studies published in the journal Cell in November, an Ebola mutation may have allowed the virus to infect humans more easily than the original. The 2014 outbreak resulted in approximate...
Source: Science - The Huffington Post - November 4, 2016 Category: Science Source Type: news

A Virus Mutation Is What Made The 2014 Ebola Outbreak So Deadly
The Ebola outbreak that devastated West Africa in 2014 was a product of multiple factors, including a population that relies increasingly on global travel, poverty and inadequate public health infrastructure on the ground and local burial practices that conflicted with medical advice. Now, we know about another factor that helped the outbreak spread: the virus mutated. Mutation is standard among viruses, and according to two cell model studies published in the journal Cell in November, an Ebola mutation may have allowed the virus to infect humans more easily than the original. The 2014 outbreak resulted in approximate...
Source: Healthy Living - The Huffington Post - November 4, 2016 Category: Consumer Health News Source Type: news

Ebola Virus Mutated to Become More Infectious, Scientists Say
Virologists hope this information will help them better prepare for the next outbreak Source: HealthDay Related MedlinePlus Page: Ebola (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 3, 2016 Category: Consumer Health News Source Type: news

Strongest Evidence Yet for Zika Link to Guillain-Barre Strongest Evidence Yet for Zika Link to Guillain-Barre
A new study has shown the presence of Zika virus on PCR virologic testing in Colombian patients with Guillain-Barre syndrome.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 6, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

New insight into course and transmission of Zika infection
(Beth Israel Deaconess Medical Center) In one of the first and largest studies of its kind, a research team lead by virologists at Beth Israel Deaconess Medical Center has characterized the progression of two strains of the viral infection. The study, published online this week in Nature Medicine, revealed Zika's rapid infection of the brain and nervous tissues, and provided evidence of risk for person-to-person transmission. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 6, 2016 Category: Infectious Diseases Source Type: news

HCV Eradication, Gut Dysbiosis, and Inflammation in Cirrhosis HCV Eradication, Gut Dysbiosis, and Inflammation in Cirrhosis
This study aimed to determine the impact of sustained virological response on gut dysbiosis and systemic inflammation in patients with cirrhosis due to HCV.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Study explains how an intestinal microbe protects against other, more dangerous bacteria
Working in animal models, scientists have found that an enzyme produced by one microbe can shield the gut against attack from other, more harmful bacteria. The findings could potentially inform the design of new probiotics for use against dangerous pathogens like those spreading hospital-acquired infections. More » (Source: The Rockefeller University Newswire)
Source: The Rockefeller University Newswire - October 3, 2016 Category: Biomedical Science Authors: Geoffrey Shearer Tags: Science News Clostridium difficile Daniel Mucida Enterococcus faecium Howard Hang immunology Kavita Rangan microbiology microbiome probiotics Virginia Pedicord Virology Source Type: news

[This Week in Science] Modeling hepatitis A in mice
Author: Kristen L. Mueller (Source: ScienceNOW)
Source: ScienceNOW - September 29, 2016 Category: Science Authors: Kristen L. Mueller Tags: Virology Source Type: news

Scientists uncover a clever ranking strategy bacteria use to fight off viruses
Like humans, bacteria come under attack from viruses—and their immune systems, like ours, are capable of remembering a virus so as to preempt any future invasion. New research explores how the bacterial immune system CRISPR stores and ranks these memories. More » (Source: The Rockefeller University Newswire)
Source: The Rockefeller University Newswire - September 19, 2016 Category: Biomedical Science Authors: Wynne Perry Tags: Science News biotechnology CRISPR immunology Jon McGinn Laboratory of Bacteriology Luciano Marraffini microbiology phage Virology Source Type: news

In the News – New York Times – Rice
Lasker Awards Given for Work in Physiology, Virology and Science Education   “At the time, researchers thought the work might be as simple as inserting that newly sequenced RNA into cultured cells and watching it replicate. But in experiment after … More » (Source: The Rockefeller University Newswire)
Source: The Rockefeller University Newswire - September 13, 2016 Category: Biomedical Science Authors: Katie Fenz Tags: In the News Charles M. Rice hepatitis C Lasker Award Lasker Award for Clinical Medical Research Lasker-DeBakey Clinical Medical Research Award Source Type: news

Lasker Awards Given for Work in Physiology, Virology and Science Education
This year ’ s honors speak to the additive nature of scientific research, with prizes recognizing people who built on the findings of others. (Source: NYT Health)
Source: NYT Health - September 13, 2016 Category: Consumer Health News Authors: STEPH YIN Tags: Lasker Awards Hepatitis hematology Alberts, Bruce M Kaelin, William G. Ratcliffe, Peter J. Semenza, Gregg L. Bartenschlager, Ralf F. W. Rice, Charles M. Sofia, Michael J. Source Type: news

Charles M. Rice wins Lasker Award for groundbreaking work on the hepatitis C virus
This year’s Lasker-DeBakey Clinical Medical Research Award honors Charles M. Rice, who developed a system to study the replication of the virus that causes hepatitis C, an advance that has led to safe and powerful new drugs that cure the disease. The award, considered the most coveted American prize in medical science, will be presented on September 23 in New York City. More » (Source: The Rockefeller University Newswire)
Source: The Rockefeller University Newswire - September 13, 2016 Category: Biomedical Science Authors: Geoffrey Shearer Tags: Awards and Honors Charles M. Rice hepatitis C hepatitis C virus Laboratory of Virology and Infectious Disease Lasker Award Lasker Award for Clinical Medical Research Lasker-DeBakey Clinical Medical Research Award Source Type: news

HCV Treatment Failure and Risk of Hepatocellular Carcinoma HCV Treatment Failure and Risk of Hepatocellular Carcinoma
Are patients with hepatitis C who receive antiviral treatment but fail to achieve sustained virological response more likely to develop hepatocellular carcinoma than untreated patients?Journal of Viral Hepatitis (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - September 9, 2016 Category: Radiology Tags: Gastroenterology Journal Article Source Type: news

Danaher to buy Cepheid in $4B deal to expand in diagnostics
(Reuters) –Danaher Corp. (NYSE:DHR) said on Tuesday it would buy molecular diagnostics company Cepheid in a deal valued at $4 billion, including debt, to strengthen its diagnostics business. Danaher will pay $53 per share in cash, a premium of 54% to Cepheid’s close of $34.42 on Friday. Danaher, which develops technology for the dental, life sciences, diagnostics and environmental industries, said the addition of Cepheid would improve operational efficiencies and expand margins in its $5 billion diagnostics business. Sunnyvale, California-based Cepheid develops molecular systems and tests for institutions to pe...
Source: Mass Device - September 6, 2016 Category: Medical Equipment Authors: MassDevice Tags: Business/Financial News Mergers & Acquisitions Cepheid Danaher Corp. Source Type: news

HPV infection rates plummet after vaccine with China the next frontier
A decade after the vaccine was introduced, research shows dramatic success. Australian scientist Ian Frazer says his collaborator Jian Zhou will be ‘vindicated’ when it becomes available in the Chinese market this yearThe virologist and cancer researcher Dr Jian Zhou had an important goal after creating a vaccine for the cancer-causing human papillomavirus in a Queensland laboratory.He wanted to see the vaccine made widely available in his home country of China, which today accounts for more than 28% of the world ’s cervical cancer cases. Cervical cancer is also the second most common cancer in Chinese wo...
Source: Guardian Unlimited Science - September 4, 2016 Category: Science Authors: Melissa Davey Tags: HPV vaccine Health Vaccines and immunisation Cancer Science Health (Australia) China Australia news Medical research Source Type: news

[This Week in Science] New insights into norovirus entry
Author: Kristen L. Mueller (Source: ScienceNOW)
Source: ScienceNOW - August 25, 2016 Category: Science Authors: Kristen L. Mueller Tags: Virology Source Type: news

University of Maryland receives $14.4 million for HIV study
The Institute of Human Virology at the University of Maryland School of Medicine received a $14.4 million grant for HIV research. The grant, awarded by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), will fund research aimed at tackling a significant scientific challenge in HIV vaccine research — the inability to produce long-lasting antibodies to protect against the infection. "Since our group co- discovered HIV as the cause of AIDS in the early 1980s, I have long stated… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 22, 2016 Category: Pharmaceuticals Authors: Morgan Eichensehr Source Type: news

Chinese researchers reveal redox sensor protein role in pathogenic mycobacteria
(Chinese Academy of Sciences Headquarters) A new research report appearing on Aug. 30, 2016, in Cell Reports dissects the cellular role of WhiB6, one of the WhiB redox sensor family proteins, in virulence and intracellular survival of pathogenic mycobacteria, according to researchers from the Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 19, 2016 Category: Biology Source Type: news

Common cold viruses originated in camels -- just like MERS
(German Center for Infection Research) There are four globally endemic human coronaviruses which, together with the better known rhinoviruses, are responsible for causing common colds. Usually, infections with these viruses are harmless to humans. DZIF Professor Christian Drosten, Institute of Virology at the University Hospital of Bonn, and his research team have now found the source of 'HCoV-229E,' one of the four common cold coronaviruses -- it also originates from camels, just like the dreaded MERS virus. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 18, 2016 Category: Infectious Diseases Source Type: news

Virologic Failure After Treatment Initiation in Acute HIV Virologic Failure After Treatment Initiation in Acute HIV
What do we know about viral dynamics after the initiation of antiretroviral therapy during acute HIV infection?AIDS (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - August 17, 2016 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Predicting Virological Decay in Patients Starting cART Predicting Virological Decay in Patients Starting cART
Learn how virological decay may be estimated in treatment-naive HIV patients after the initiation of cART.AIDS (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - August 10, 2016 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Wiley provides free access to latest Zika research to coincide with events in Brazil
Wiley has made available all of its published Zika content on one sitewww.wiley.com/go/zika to coincide with events in Brazil, a territory that has seen increased cases of Zika Virus recently. Access will be freely available until 30 September. New research from medicine, entomology, obstetrics, neuroscience and more will be added to Wiley’s Zika page as it becomes available along with interactive content such as interviews, podcasts and videos, providing the latest updates on Zika virus. Zika virus is transmitted primarily by Aedes mosquitoes and has been linked to causing neurological complications in humans. Recen...
Source: News from STM - August 9, 2016 Category: Databases & Libraries Authors: STM Publishing News Tags: Featured World Source Type: news

Zika Virus: Pediatric Grand Round
University of California, Los Angeles (UCLA) Mattel Children's Hospital. 03/04/2016This 51-minute presentation reviews the background epidemiology, biology, and virology of the Zika virus. It discusses some research questions and challenges of current research about Zika; the link between Zika infection, microcephaly, and other potential complications; and work in progress on Zika transmission. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - July 19, 2016 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

Zika Diagnostic Tools, Testing Algorithms, and Interpretation Guidance
Centers for Disease Control and Prevention. 06/13/2016This 29-page document provides presentation slides from a teleconference that is part of a series of Zika Action Plan (ZAP) Summit follow-up teleconferences. Speakers discuss Zika Virology and History, Zika Diagnostics, Diagnostic Testing Algorithms, and Test Interpretation Guidance. Other topics include Surge Capacity for Zika Diagnostic Testing in the U.S., and the U.S. Pregnancy Registries. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - July 18, 2016 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

Cancer-fighting gene immunotherapy shows promise as treatment for HIV
A type of immunotherapy that has shown promising results against cancer could also be used against HIV, the virus that causes AIDS. In a study published July 11 in the peer-reviewed Journal of Virology, researchers from the UCLA AIDS Institute and Center for AIDS Research found that recently discovered potent antibodies can be used to generate a specific type of cell called chimeric antigen receptors, or CARs, that can be used to kill cells infected with HIV-1. CARs are artificially created immune T cells that have been engineered to produce receptors on their surface that are designed to target and kill specific cells con...
Source: UCLA Newsroom: Health Sciences - July 15, 2016 Category: Universities & Medical Training Source Type: news

Study examines risk of HIV transmission from condomless sex with virologically suppressed HIV infection
Among nearly 900 serodifferent (one partner is HIV-positive, one is HIV-negative) heterosexual and men who have sex with men couples in which the HIV-positive partner was using suppressive antiretroviral therapy and who reported condomless sex, during a median follow-up of 1.3 years per couple, there were no documented cases of within-couple HIV transmission, according to a new study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 12, 2016 Category: Science Source Type: news

Researchers Cast Doubt on CRISPR-Like System in Giant Viruses
Virologists challenge the hypothesis that mimiviruses posses a nucleic acid defense mechanism. (Source: The Scientist)
Source: The Scientist - July 7, 2016 Category: Science Tags: Daily News Source Type: news

UMN researchers find distinct differences in structure, features of retroviruses
(University of Minnesota Academic Health Center) In the most comprehensive study of its kind, researchers in the Institute for Molecular Virology and School of Dentistry at the University of Minnesota report that most types of retroviruses have distinct, non-identical virus structures. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 5, 2016 Category: Cancer & Oncology Source Type: news

Cancer-fighting gene immunotherapy shows promise as possible treatment for HIV
A type of immunotherapy that has shown promising results against cancer could also be used against HIV, the virus that causes AIDS. In a study published July 11 in the peer-reviewed Journal of Virology, researchers from the UCLA AIDS Institute and Center for AIDS Research found that recently discovered potent antibodies can be used to generate a specific type of cell called chimeric antigen receptors, or CARs, that can be used to kill cells infected with HIV-1. CARs are artificially created immune T cells that have been engineered to produce receptors on their surface that are designed to target and kill specific cells con...
Source: UCLA Newsroom: Health Sciences - June 29, 2016 Category: Universities & Medical Training Source Type: news

Rory McIlroy Pulls Out Of Olympics Over Zika Fears
By Adrian Warner LONDON (Reuters) - Northern Ireland's four-times major winner Rory McIlroy has decided to pull out of the historic golf tournament at the Rio Olympic Games in August because of health fears over the Zika virus. "After speaking with those closest to me, I've come to realize that my health and my family's health comes before anything else," the world number four said in a statement on Wednesday. "Even though the risk of infection from the Zika virus is considered low, it is a risk nonetheless and a risk I am unwilling to take." The International Golf Federation (IGF) said it was disappoin...
Source: Healthy Living - The Huffington Post - June 22, 2016 Category: Consumer Health News Source Type: news

Zika Virus!: This Week in Virology Live from the American Society for Microbiology
American Society for Microbiology. 05/31/2016This one-hour, 24-minute video features a conversation with four leading experts on flaviviruses to discuss what is known about the emerging pathogen Zika virus, and the state of ongoing research where the experts work. Topics include the interface between viral pathogenesis and the host immune response for several globally important mosquito-borne human pathogens, including West Nile, dengue, Zika, and chikungunya viruses; how the interplay between viruses and the host's immune system impacts the outcome of viral infection and disease; and how viruses propagate. (Video or Multi...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - June 17, 2016 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

Study enables first-time analysis of earliest stage of HIV infection
The first days after HIV infection are very important because sexual partners are exposed to extremely high risks of infection due to the subsequent high viral load in the infected person. Additionally, this period of time determines the further course of HIV infection. Scientists in Tanzania participated in a prospective, multinational study which investigated virological and immunological changes due to HIV. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 14, 2016 Category: Science Source Type: news

Timing, resistant varieties help decrease wheat virus
Strategically timed planting and using resistant wheat varieties help decrease virus incidence, according to a virologist. The plant science professor has been working on wheat viruses for more than 25 years. The major culprit in South Dakota is wheat streak mosaic virus. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 1, 2016 Category: Science Source Type: news

NRTI Sparing Therapy in Virologically Controlled HIVNRTI Sparing Therapy in Virologically Controlled HIV
This study explores the combination of rilpivirine plus boosted darunavir as an option when switching from standard cART in patients who are virologically suppressed. JAIDS: Journal of Acquired Immune Deficiency Syndromes (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - June 1, 2016 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Nigeria: 3.2 Million People Living With HIV, Says Expert
[This Day] The Chief Executive Officer of the Institute of Human Virology if Nigeria, IHVN, Dr. Patrick Dakum, has revealed that Nigeria has more children living with Human Immuno Virus, HIV, in the world, and that about 3.2 million people are living with the virus in the country. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - May 29, 2016 Category: Infectious Diseases Source Type: news

Opinion: The Zika Effect
Three reasons why virologists are flocking to study this emerging virus. (Source: The Scientist)
Source: The Scientist - May 27, 2016 Category: Science Tags: News & Opinion, Opinion Source Type: news

Opinion: The Zika Effect
Three reasons why virologists are flocking to study this emerging virus (Source: The Scientist)
Source: The Scientist - May 27, 2016 Category: Science Tags: News & Opinion, Opinion Source Type: news

Novel Drug Combo Succeeds Against Multiple HCV Genotypes (CME/CE)
(MedPage Today) -- No cases of virologic failure observed with ABT-493 plus ABT-530 (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 25, 2016 Category: Gastroenterology Source Type: news

Nigeria: 'Nigeria Should Worry About Spread of Zika, Yellow Fever'
[Vanguard] Renowned Virologist and President of the Nigeria Academy of Science, Professor Oyewale Tomori, has said the discovery of a strain of Zika virus circulating in Brazil and other parts of the Americas in the Cape Verde area of Africa, should worry Nigeria. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 23, 2016 Category: African Health Source Type: news

New strategy could yield more precise seasonal flu vaccine
(University of Wisconsin-Madison) A team of researchers led by University of Wisconsin-Madison School of Veterinary Medicine virologist Yoshihiro Kawaoka describes a novel strategy to predict the antigenic evolution of circulating influenza viruses and give science the ability to more precisely anticipate seasonal flu strains. It would foster a closer match for the so-called 'vaccine viruses' used to create the world's vaccine supply. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 23, 2016 Category: Infectious Diseases Source Type: news